Patients with diabetes receiving treatment for CRC may experience more neuropathic symptoms
the ONA take:
Patients with colorectal cancer who also have diabetes experienced more neuropathic symptoms, regardless of cancer treatment, according to a recent study published in the Journal of Cancer Survivorship.
Researchers found that patients with colorectal cancer and diabetes experienced more mild to severe neuropathic symptoms, including tingling fingers or hands, tingling toes or feet, numbness in toes or feet, and erectile dysfunction among men, than patients without diabetes.
The study demonstrated no differences in cancer treatment between patients with colorectal cancer and diabetes compared with those without diabetes.
The authors conclude that diabetes rather than chemotherapy results in more neuropathic symptoms among patients with cancer and diabetes compared with those without diabetes.
The findings ultimately suggest that up to 39% of cancer survivors might expect mostly mild, neuropathic symptoms, with more symptoms occurring in patients with diabetes.
Neuropathic symptoms are typically associated with the chemotherapy agent oxaliplatin, which is often used in combination with fluorouracil, leucovorin, and sometimes irinotecan in the treatment of colorectal cancer.
Patients with colorectal cancer who also have diabetes experienced more neuropathic symptoms, regardless of cancer treatment.
Sign Up for Free e-newsletters
- Distress, Neuroticism Predict Long-term Emotional Distress After Cancer Diagnosis
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Bacteria in Probiotics Carry Potential Risks for Immunocompromised Patients
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- Overall Survival Prolonged With HIPEC + Cytoreductive Surgery for Gastric Cancer
- Better Postoperative Outcomes With RAMIE for Esophageal Cancer
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|